By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Calithera Biosciences, Inc. 

7000 Shoreline Court
Suite 255
South San Francisco  California  94080  U.S.A.
Phone: n/a Fax: n/a



Company News
Calithera Biosciences, Inc. (CALA) To Present At The Biotechnology Industry Organization (BIO) CEO & Investor And Leerink Global Healthcare Conferences In February 2/3/2015 8:41:49 AM
Calithera Biosciences, Inc. (CALA) Appoints Keith Orford, M.D., Ph.D. To Vice President Of Clinical Development 1/30/2015 7:43:27 AM
Calithera Biosciences, Inc. (CALA) Presents Novel Pharmacodynamic Assay Data Confirming Glutaminase Inhibition In Tumor Biopsy Samples From Patients Treated With CB-839 12/11/2014 7:33:04 AM
Calithera Biosciences, Inc. (CALA) Gains Exclusive, Worldwide License To Mars Symbioscience's Arginase Inhibitors 12/9/2014 10:41:51 AM
Calithera Biosciences, Inc. (CALA) Presents Preclinical Study Findings For CB-839 At The 56th American Society of Hematology Annual Meeting 12/9/2014 10:36:13 AM
Calithera Biosciences, Inc. (CALA) Appoints H. Ward Wolff To Board Of Directors 12/5/2014 10:54:38 AM
Calithera Biosciences, Inc. (CALA) Reports Financial Results For The Fiscal Quarter Ended September 30, 2014 11/14/2014 7:47:50 AM
SSF's Calithera Biosciences, Inc. (CALA) Prices IPO At $10 A Share, Below The Range 10/2/2014 8:20:10 AM
South San Francisco's Calithera Biosciences, Inc. Seeks $80 Million In IPO 8/26/2014 6:24:25 AM
Calithera Biosciences, Inc. Presents Pharmacodynamic Data On CB-839 At The 2014 American Association for Cancer Research Annual Meeting 4/8/2014 6:47:50 AM